Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px
Document › Details

1st Detect Corporation. (12/13/12). "Press Release: 1st Detect Awarded U.S. Patent for Novel Mass Spectrometer Ion Trap Control Technology". Austin, TX.

Region Region United States (USA)
Organisations Organisation 1st Detect Corporation
  Group Astrotech (Group)
  Organisation 2 US Patent and Trademark Office (USPTO)
  Group United States (govt)
Products Product ion trap mass spectrometry technology
  Product 2 MMS-1000™ Miniature Mass Spectrometer
Persons Person Pickens, Thomas B. (Astrotech 201201 CEO of Astrotech + Chairman 1st Detect Corp)
  Person 2 Wylde, James (Astrotech 201201 VP Business Development at 1st Detect Corp)
     


1st Detect Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), announced today that the United States Patent Office ("USPTO") has allowed the issuance of a key patent for the company's unique method to miniaturize the electrical circuitry for a mass spectrometer ion trap used for chemical analysis and detection.

"We are extremely pleased that the USPTO has allowed this patent. This patent is an important component of our intellectual property portfolio as it allows 1st Detect to miniaturize mass spectrometers without sacrificing performance." said Thomas B Pickens III, Chairman and CEO of 1st Detect. "The patent clearly validates our technology and both demonstrates, and protects the progress we have made in the development of the 1st Detect Miniature Mass Spectrometer."

The patent, entitled "End Cap Voltage Control of Ion Traps", published as USPTO No. 8,334,506, represents a key technological advantage for 1st Detect to optimize the operation of an ion trap using compact and efficient circuitry.

"The technology protected by this patent supports our objective to offer the most affordable, high performance miniature mass spectrometer for both laboratory and field applications." added David Rafferty, the inventor of the novel technology and President and CTO of 1st Detect.

1st Detect Corporation has developed an instrument that revolutionizes the chemical detection and analysis market by delivering lab performance mass spectrometry in a small, affordable and easily portable package. The 1st Detect mini mass spectrometer's broad capabilities make it an ideal tool for a variety of applications in the research, security, industrial, process flow and healthcare markets; and is capable of detecting a wide variety of chemicals including residues and vapors from explosives, chemical warfare agents, toxic chemicals, food and beverage contaminants and pollution products.


About 1st Detect Corporation

1st Detect Corporation was formed by Astrotech Corporation (Nasdaq:ASTC) to develop and commercialize miniature mass spectrometer technology first developed under an agreement with NASA for use on the International Space Station. 1st Detect offers a breakthrough miniature mass spectrometer that fills an unmet need by being highly accurate, rapid, lightweight, and cost-effective.


About Astrotech Corporation

Astrotech is one of the first space commerce companies and remains a strong entrepreneurial force in the aerospace industry. We are leaders in identifying, developing and marketing space technology for commercial use. Our Astrotech Space Operations business unit serves our government and commercial satellite and spacecraft customers with pre-launch services on the eastern and western range. 1st Detect Corporation is developing a breakthrough miniature mass spectrometer, while Astrogenetix, Inc. is a biotechnology company utilizing microgravity as a research platform for drug discovery and development.


This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, continued government support and funding for key space programs, product performance and market acceptance of products and services, as well as other risk factors and business considerations described in the Company's Securities and Exchange Commission filings including the annual report on Form 10-K. Any forwardlooking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.


FOR MORE INFORMATION:

James Wylde
Vice President, Business Development
1st Detect Corporation
972-617-9939
jwylde@1stdetect.com


1st Detect Corporation
401 Congress Ave, Suite 1650
Austin TX 78701
Phone: +1.512.485.9530
Fax: +1.512.485.9531
www.1stdetect.com

   
Record changed: 2016-03-19

Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px

More documents for Astrotech (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px